You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-Proliferative MPN

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial in Chengdu (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

Recruiting
  • Myeloproliferative Neoplasm (MPN)
  • Myelofibrosis，MF
  • flonoltinib 25mg
  • +5 more
  • Chengdu, Sichuan, China
    West China Hospital Sichuan University
Mar 9, 2022

Non-proliferative Diabetic Retinopathy Trial (OTX-TKI, Sham)

Not yet recruiting
  • Non-proliferative Diabetic Retinopathy
  • (no location specified)
Jan 12, 2023

Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

Not yet recruiting
  • Myeloproliferative Neoplasm (MPN)
  • Myelofibrosis，MF
  • flonoltinib 25mg
  • +5 more
  • (no location specified)
Nov 2, 2021

Non Proliferative Diabetic Retinopathy(NPDR) Trial in Tianjin (pars plana vitrectomy(PPV), Pars plana vitrectomy(PPV)

Not yet recruiting
  • Non Proliferative Diabetic Retinopathy(NPDR)
  • pars plana vitrectomy(PPV)
  • +2 more
  • Tianjin, China
    Tianjin medical university eye hospital
May 10, 2023

Non Proliferative Diabetic Retinopathy Trial in Seoul (Entelon Tab. 50mg, Placebo)

Recruiting
  • Non Proliferative Diabetic Retinopathy
  • Entelon Tab. 50mg
  • Placebo
  • Seoul, Korea, Republic of
    Hallym University Kangnam Sacred Heart Hospital
Jul 19, 2022

Eyes With Non Proliferative Diabetic Retinopathy in Diabetes

Recruiting
  • NPDR - Non Proliferative Diabetic Retinopathy
  • +2 more
  • Biomarkers
  • Dijon, France
  • +4 more
Jul 18, 2022

Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection

Recruiting
  • Mild Non-proliferative Diabetic Retinopathy
  • +2 more
  • Ranibizumab Injection [Lucentis]
  • Phacoemulsification
  • Shanghai, Shanghai, China
    Department of Ophthalmology, Ruijin Hospital Affiliated Medical,
May 18, 2022

Non-Proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (Faricimab)

Not yet recruiting
  • Non-Proliferative Diabetic Retinopathy
  • Bakersfield, California
  • +18 more
Jan 25, 2023

Prophylactic PRP in Moderate NPDR

Completed
  • Eye Diseases
  • +2 more
  • PRP
  • Assiut, Egypt
    Assiut University
Sep 14, 2022

Dyslipidemia and Diabetic Retinopathy

Recruiting
  • Diabetic Retinopathy
  • Dyslipidemia
  • 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
  • Healthy Controls 15 age matched control subjects
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 11, 2022

Leukemia, Leukemia, Myeloid, Monocytic Leukemia Trial in Palo Alto (Enasidenib mesylat dose escalation)

Recruiting
  • Leukemia
  • +2 more
  • Enasidenib mesylat dose escalation
  • Palo Alto, California
    Stanford Cancer Institute
May 12, 2022

Non-proliferative Diabetic Retinopathy Trial in United States (OPL-0401 Dose 1, OPL-0401 Dose 2, Placebo)

Recruiting
  • Non-proliferative Diabetic Retinopathy
  • OPL-0401 Dose 1
  • +2 more
  • Mountain View, California
  • +20 more
Dec 16, 2022

Breast Cancer Trial in Baltimore (Anastrozole, Letrozole)

Recruiting
  • Breast Cancer
  • Baltimore, Maryland
    University of Maryland Greenebaum Cancer Center
Apr 29, 2022

Type2 Diabetes, Diabetic Retinopathy Trial in China (Tangningtongluo tablets, Calcium dobesilate capsules)

Recruiting
  • Type2 Diabetes
  • Diabetic Retinopathy
  • Tangningtongluo tablets
  • Calcium dobesilate capsules
  • Chongqing, Chongqing, China
  • +9 more
Jun 27, 2022

Diabetic Retinopathy Trial in United Kingdom (Fenofibrate 145 mg, Placebo Oral Tablet)

Active, not recruiting
  • Diabetic Retinopathy
  • Fenofibrate 145 mg
  • Placebo Oral Tablet
  • Aberdeen, United Kingdom
  • +15 more
Jun 8, 2022

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

Non-proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (KSI-301, Sham injection)

Active, not recruiting
  • Non-proliferative Diabetic Retinopathy
  • Phoenix, Arizona
  • +46 more
Sep 22, 2022

MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)

Recruiting
  • Myelodysplastic Syndromes
  • MDS/MPN Crossover Syndromes
  • Cleveland, Ohio
    Cleveland Medical Center, University Hospitals Seidman Cancer Ce
Aug 10, 2022

NPDR - Non Proliferative Diabetic Retinopathy Trial in Coimbra (Laboratory tests)

Completed
  • NPDR - Non Proliferative Diabetic Retinopathy
  • Laboratory tests
  • Coimbra, Portugal
    AIBILI- Association for Biomedical Research and Inovation on Lig
Oct 11, 2022

Anti-VEGF in Real-world

Recruiting
  • Neovascular Age-related Macular Edema
  • +5 more
  • Beijing, Beijing, China
    Wen-Bin Wei
Feb 2, 2022

Proliferative Diabetic Retinopathy Trial in United States (Aflibercept)

Completed
Has Results
  • Proliferative Diabetic Retinopathy
  • Houston, Texas
  • +3 more
May 20, 2021

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Diabetic Macular Edema Trial in Riyadh (Bevacizumab)

Completed
  • Non-proliferative Diabetic Retinopathy
  • +2 more
  • Riyadh, Saudi Arabia
    King Khaled Eye Specialist Hospital
Dec 2, 2021

Diabetic Retinopathy Trial in Worldwide (Runcaciguat (BAY1101042), Placebo)

Recruiting
  • Diabetic Retinopathy
  • Runcaciguat (BAY1101042)
  • Placebo
  • Redlands, California
  • +85 more
Jan 30, 2023